Cargando…
Irbesartan in experimental diabetic nephropathy
Autores principales: | Mahajan, Rajiv, Gupta, Kapil, Singh, Navyug Raj |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937327/ https://www.ncbi.nlm.nih.gov/pubmed/20871777 http://dx.doi.org/10.4103/0253-7613.66849 |
Ejemplares similares
-
Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009) -
Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011) -
Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022) -
A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
por: Yoo, Seo Yeon, et al.
Publicado: (2022) -
Cytochrome modulation decreases the risk of cataract: Is the basic hypothesis flawless?
por: Mahajan, Rajiv, et al.
Publicado: (2009)